Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.870
-0.090 (-3.04%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Adverum Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
609776581731,057
Upgrade
Market Cap Growth
27.74%27.74%31.60%-66.55%-83.65%42.01%
Upgrade
Enterprise Value
281734-40-38633
Upgrade
Last Close Price
2.964.677.535.7917.60108.40
Upgrade
PS Ratio
58.5597.1521.13-23.03-
Upgrade
PB Ratio
0.871.371.130.320.552.43
Upgrade
P/TBV Ratio
0.871.371.130.320.552.43
Upgrade
EV/Sales Ratio
27.8517.179.58---
Upgrade
Debt / Equity Ratio
1.301.301.100.590.330.07
Upgrade
Asset Turnover
0.010.010.02-0.02-
Upgrade
Quick Ratio
5.495.494.835.7614.5820.59
Upgrade
Current Ratio
5.735.735.145.9114.8820.82
Upgrade
Return on Equity (ROE)
-189.84%-189.84%-98.19%-62.10%-38.78%-38.57%
Upgrade
Return on Assets (ROA)
-51.83%-51.83%-34.73%-25.11%-19.66%-20.90%
Upgrade
Return on Capital (ROIC)
-57.28%-57.28%-37.52%-26.56%-20.51%-21.93%
Upgrade
Earnings Yield
-211.73%-134.77%-160.57%-267.40%-84.25%-11.12%
Upgrade
FCF Yield
-150.16%-95.58%-120.59%-207.48%-71.17%-8.63%
Upgrade
Buyback Yield / Dilution
-96.21%-96.21%-1.58%-1.24%-15.14%-32.83%
Upgrade
Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q